Saved in:
| Main Authors: | Andrée‐Ann Baril, Cynthia Picard, Anne Labonté, Erlan Sanchez, Catherine Duclos, Béry Mohammediyan, Nicholas J. Ashton, Henrik Zetterberg, Kaj Blennow, John C. S. Breitner, Sylvia Villeneuve, Judes Poirier |
|---|---|
| Format: | Artículo Open Access |
| Published: |
Wiley
2024
|
| Subjects: | |
| Online Access: | https://alz-journals.onlinelibrary.wiley.com/doi/10.1002/dad2.12521 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
Self‐reported and objectively assessed insomnia symptom severity and cognitive markers in dementia‐free older adults at‐risk for Alzheimer's disease
by: Bery Mohammediyan, et al.
Published: (2025)
by: Bery Mohammediyan, et al.
Published: (2025)
Synaptic proteins in pre‐symptomatic Alzheimer's disease: genes implicate synaptic biomarkers to the early detection of cognitive decline
by: Jiarui Ao, et al.
Published: (2024)
by: Jiarui Ao, et al.
Published: (2024)
Complement proteins C1q, C3, and Factor H are associated with early tau pathology and synaptic integrity in persons with pre‐symptomatic Alzheimer’s disease
by: Julia Loncke, et al.
Published: (2024)
by: Julia Loncke, et al.
Published: (2024)
Relationship between complement protein levels and tau pathology in pre‐symptomatic Alzheimer's disease resembles patterns observed in MCI
by: Julia Loncke, et al.
Published: (2025)
by: Julia Loncke, et al.
Published: (2025)
The IL‐18 signaling cascade is implicated in aging, tau pathology and synaptic degeneration
by: Isabel MacKenzie Sarty, et al.
Published: (2025)
by: Isabel MacKenzie Sarty, et al.
Published: (2025)
Association of plasma GFAP with elevated brain amyloid is dependent on severity of white matter lesions in an Asian cognitively impaired cohort
by: Joyce R. Chong, et al.
Published: (2024)
by: Joyce R. Chong, et al.
Published: (2024)
Association between BrainAGE and Alzheimer's disease biomarkers
by: Yousaf Abughofah, et al.
Published: (2025)
by: Yousaf Abughofah, et al.
Published: (2025)
Tracking clinical and neuroimaging progression of Alzheimer's disease by longitudinal trajectories of plasma biomarkers
by: Frederikke Kragh Clemmensen, et al.
Published: (2026)
by: Frederikke Kragh Clemmensen, et al.
Published: (2026)
PTPRS is a novel marker for early tau pathology and synaptic integrity in Alzheimer’s disease
by: Alexandre Poirier, et al.
Published: (2024)
by: Alexandre Poirier, et al.
Published: (2024)
Brain‐derived tau to measure treatment effect in Alzheimer's disease and frontotemporal dementia
by: Cassandra Marotta, et al.
Published: (2025)
by: Cassandra Marotta, et al.
Published: (2025)
Longitudinal association between CSF markers of Alzheimer Disease and inflammation in preclinical Alzheimer Disease
by: Isabel MacKenzie Sarty, et al.
Published: (2024)
by: Isabel MacKenzie Sarty, et al.
Published: (2024)
Relationship of plasma biomarkers to digital cognitive tests in Alzheimer's disease
by: Sofia Toniolo, et al.
Published: (2024)
by: Sofia Toniolo, et al.
Published: (2024)
Amyloid is associated with accelerated atrophy in cognitively unimpaired individuals
by: Henry Gilreath Stephenson, et al.
Published: (2025)
by: Henry Gilreath Stephenson, et al.
Published: (2025)
Cardiovascular rate pressure product is associated with NfL in older adults at risk for AD
by: Chinenye C. Odo, et al.
Published: (2025)
by: Chinenye C. Odo, et al.
Published: (2025)
The role of clusterin and the variant rs11136000_T throughout the spectrum of Alzheimer’s disease
by: Marina Tedeschi Dauar, et al.
Published: (2024)
by: Marina Tedeschi Dauar, et al.
Published: (2024)
Criterion and convergent validity of plasma biomarkers in early‐onset Alzheimer's disease: Initial findings from LEADS
by: Dustin B. Hammers, et al.
Published: (2026)
by: Dustin B. Hammers, et al.
Published: (2026)
Cerebrospinal fluid YKL‐40 relates to white matter hyperintensity progression in females but not males over a 6‐year period
by: Amalia J. Peterson, et al.
Published: (2025)
by: Amalia J. Peterson, et al.
Published: (2025)
The Association of Prenatal Alcohol Exposure With Brain Development During the First 1000 Days of Life: A Systematic Review
by: Marin Pielage, et al.
Published: (2024)
by: Marin Pielage, et al.
Published: (2024)
Web‐based LAS‐FNAME and blood biomarkers in autosomal dominant Alzheimer's disease
by: Christopher Gonzalez Corona, et al.
Published: (2026)
by: Christopher Gonzalez Corona, et al.
Published: (2026)
Artificial intelligence‐based diagnosis in fetal pathology using external ear shapes
by: Quentin Hennocq, et al.
Published: (2024)
by: Quentin Hennocq, et al.
Published: (2024)
Biofluid‐based biomarkers for tau pathophysiology in Alzheimer's disease
by: Henrik Zetterberg, et al.
Published: (2025)
by: Henrik Zetterberg, et al.
Published: (2025)
The role of tau and amyloid pathology in neurosensory impairments during preclinical Alzheimer's disease
by: Daniel C Bowie, et al.
Published: (2025)
by: Daniel C Bowie, et al.
Published: (2025)
Dengue fever as a cause of hemophagocytic lymphohistiocytosis
by: Noely Hein
Published: (2015)
by: Noely Hein
Published: (2015)
Screening tools for oropharyngeal dysphagia in stroke
by: Tatiana Magalhães de Almeida
Published: (2015)
by: Tatiana Magalhães de Almeida
Published: (2015)
Perceptions of cognitive decline among American Indian and Alaska Native elders
by: Cole Allick
Published: (2024)
by: Cole Allick
Published: (2024)
Placental and Fetal Brain Volumes in Congenital Heart Disease Are Smallest Among Fetuses With Genetic Abnormalities
by: Sonali Ajwani, et al.
Published: (2025)
by: Sonali Ajwani, et al.
Published: (2025)
Preclinical dementia rating scores are associated with plasma phosphorylated tau‐217
by: Qi Huang, et al.
Published: (2025)
by: Qi Huang, et al.
Published: (2025)
Exploring the relationship between melanopsin gene variants, sleep, and markers of brain health
by: Ayeisha Milligan Armstrong, et al.
Published: (2025)
by: Ayeisha Milligan Armstrong, et al.
Published: (2025)
Clinical and demographic factors modify the association between plasma phosphorylated tau‐181 and cognition
by: Corey J. Bolton, et al.
Published: (2024)
by: Corey J. Bolton, et al.
Published: (2024)
Excessive sleep is associated with worse cognition, cognitive decline, and dementia in mild cognitive impairment
by: Marieclaire Overton, et al.
Published: (2025)
by: Marieclaire Overton, et al.
Published: (2025)
Evaluation of two clinical Centiloid analysis products for 18F‐florbetapir PET in cognitively unimpaired elders
by: Frank P. DiFilippo, et al.
Published: (2025)
by: Frank P. DiFilippo, et al.
Published: (2025)
Online46: Online cognitive assessments in elderly cohorts—The British 1946 birth cohort case study
by: Ziyuan Cai, et al.
Published: (2025)
by: Ziyuan Cai, et al.
Published: (2025)
Impact of sleep disruptions on gray matter structural covariance networks across the Alzheimer's disease continuum
by: Xiao Luo, et al.
Published: (2025)
by: Xiao Luo, et al.
Published: (2025)
Pentagon Drawing Test: some data from Alzheimer's disease, Paraphrenia and Obsessive compulsive disorder in elderly patients
by: Juliana Francisca Cecato
Published: (2016)
by: Juliana Francisca Cecato
Published: (2016)
The impact of amyloid beta burden on white matter dysfunction and associated transcriptomic signatures in cognitively normal elderly individuals
by: Ziyun Li, et al.
Published: (2025)
by: Ziyun Li, et al.
Published: (2025)
Cross‐cultural adaption of the computerized assessment of information processing battery (COGNITO) for an Indian longitudinal study on rural elderly
by: Ammu Lukose, et al.
Published: (2024)
by: Ammu Lukose, et al.
Published: (2024)
General practitioners’ perspectives on blood biomarkers for Alzheimer's disease
by: Thomas Claessen, et al.
Published: (2025)
by: Thomas Claessen, et al.
Published: (2025)
Investigating the relationship between sleep disturbances and white matter hyperintensities in older adults on the Alzheimer's disease spectrum
by: Farooq Kamal, et al.
Published: (2024)
by: Farooq Kamal, et al.
Published: (2024)
Clinical classification of memory and cognitive impairment with multimodal digital biomarkers
by: Russell Banks, et al.
Published: (2024)
by: Russell Banks, et al.
Published: (2024)
Necrotizing amebic colitis in an elder patient: an unexpected autopsy finding
by: Maria Aparecida Marchesan Rodrigues
Published: (2023)
by: Maria Aparecida Marchesan Rodrigues
Published: (2023)
Similar Items
-
Self‐reported and objectively assessed insomnia symptom severity and cognitive markers in dementia‐free older adults at‐risk for Alzheimer's disease
by: Bery Mohammediyan, et al.
Published: (2025) -
Synaptic proteins in pre‐symptomatic Alzheimer's disease: genes implicate synaptic biomarkers to the early detection of cognitive decline
by: Jiarui Ao, et al.
Published: (2024) -
Complement proteins C1q, C3, and Factor H are associated with early tau pathology and synaptic integrity in persons with pre‐symptomatic Alzheimer’s disease
by: Julia Loncke, et al.
Published: (2024) -
Relationship between complement protein levels and tau pathology in pre‐symptomatic Alzheimer's disease resembles patterns observed in MCI
by: Julia Loncke, et al.
Published: (2025) -
The IL‐18 signaling cascade is implicated in aging, tau pathology and synaptic degeneration
by: Isabel MacKenzie Sarty, et al.
Published: (2025)